Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase

Suthat Liangpunsakul, Sung Eun Wou, Kevin D. Wineinger, Yan Zeng, Izabela Cyganek, Hiremagalur N. Jayaram, David Crabb

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: AMP-dependent protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR) α facilitate fatty acid oxidation. We have shown that treatment of hepatoma cells with ethanol or feeding ethanol-containing diets to mice inhibited both PPARα and AMPK activity. Importantly, WY-14,643 reversed the development of fatty liver in alcohol-fed mice. Whether WY-14,643, a PPARα agonist, has any effects on AMPK is not known. The aim of this study was to investigate the effect of WY-14,643 on AMPK activity. Methods: The effect of WY-14,643 on AMPK phosphorylation and activity were examined in rat hepatoma cells (H4IIEC3). The effect of WY-14,643 on upstream kinases of AMPK, PKC-ζ/LKB1, intracellular AMP:ATP ratio, oxidative stress, and AMPK gene expression were studied. Results: Treatment of the H4IIEC3 cells with WY-14,643 for 24 h led to 60% increase in the phosphorylation of AMPK. The effect of WY-14,643 on AMPK phosphorylation is PKC-ζ/LKB1 independent. WY-14,643 did not alter the levels of intracellular AMP:ATP ratio and it did not increase the levels of reactive oxygen species at 24-h of treatment. WY-14,643-induced AMPK α subunit expression by 2- to 2.5-fold, but there was no change in AMPKα subunit protein at 24 h. The effect of WY-14,643 on AMPK phosphorylation did not altered by the presence of an NADPH oxidase inhibitor. Conclusions: WY-14,643 induced AMPKα subunit phosphorylation and the activity of the enzyme. This was associated with induction of AMPKα1 and α2 mRNA, but the mechanism for this activation is uncertain.

Original languageEnglish
Pages (from-to)10-15
Number of pages6
JournalArchives of Biochemistry and Biophysics
Volume485
Issue number1
DOIs
StatePublished - May 1 2009

Fingerprint

Phosphorylation
Adenosine Monophosphate
Protein Kinases
Chemical activation
Peroxisome Proliferator-Activated Receptors
Protein Subunits
pirinixic acid
Hepatocellular Carcinoma
Ethanol
Adenosine Triphosphate
Adenylate Kinase
Oxidative stress
NADPH Oxidase
Fatty Liver
Nutrition
Gene expression
Liver
Rats

Keywords

  • AMPKα
  • PPARα agonist
  • WY-14,643

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase. / Liangpunsakul, Suthat; Wou, Sung Eun; Wineinger, Kevin D.; Zeng, Yan; Cyganek, Izabela; Jayaram, Hiremagalur N.; Crabb, David.

In: Archives of Biochemistry and Biophysics, Vol. 485, No. 1, 01.05.2009, p. 10-15.

Research output: Contribution to journalArticle

Liangpunsakul, Suthat ; Wou, Sung Eun ; Wineinger, Kevin D. ; Zeng, Yan ; Cyganek, Izabela ; Jayaram, Hiremagalur N. ; Crabb, David. / Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase. In: Archives of Biochemistry and Biophysics. 2009 ; Vol. 485, No. 1. pp. 10-15.
@article{646171ab429a4a72b8e01db1ca5369e2,
title = "Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase",
abstract = "Background: AMP-dependent protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR) α facilitate fatty acid oxidation. We have shown that treatment of hepatoma cells with ethanol or feeding ethanol-containing diets to mice inhibited both PPARα and AMPK activity. Importantly, WY-14,643 reversed the development of fatty liver in alcohol-fed mice. Whether WY-14,643, a PPARα agonist, has any effects on AMPK is not known. The aim of this study was to investigate the effect of WY-14,643 on AMPK activity. Methods: The effect of WY-14,643 on AMPK phosphorylation and activity were examined in rat hepatoma cells (H4IIEC3). The effect of WY-14,643 on upstream kinases of AMPK, PKC-ζ/LKB1, intracellular AMP:ATP ratio, oxidative stress, and AMPK gene expression were studied. Results: Treatment of the H4IIEC3 cells with WY-14,643 for 24 h led to 60{\%} increase in the phosphorylation of AMPK. The effect of WY-14,643 on AMPK phosphorylation is PKC-ζ/LKB1 independent. WY-14,643 did not alter the levels of intracellular AMP:ATP ratio and it did not increase the levels of reactive oxygen species at 24-h of treatment. WY-14,643-induced AMPK α subunit expression by 2- to 2.5-fold, but there was no change in AMPKα subunit protein at 24 h. The effect of WY-14,643 on AMPK phosphorylation did not altered by the presence of an NADPH oxidase inhibitor. Conclusions: WY-14,643 induced AMPKα subunit phosphorylation and the activity of the enzyme. This was associated with induction of AMPKα1 and α2 mRNA, but the mechanism for this activation is uncertain.",
keywords = "AMPKα, PPARα agonist, WY-14,643",
author = "Suthat Liangpunsakul and Wou, {Sung Eun} and Wineinger, {Kevin D.} and Yan Zeng and Izabela Cyganek and Jayaram, {Hiremagalur N.} and David Crabb",
year = "2009",
month = "5",
day = "1",
doi = "10.1016/j.abb.2009.02.006",
language = "English",
volume = "485",
pages = "10--15",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase

AU - Liangpunsakul, Suthat

AU - Wou, Sung Eun

AU - Wineinger, Kevin D.

AU - Zeng, Yan

AU - Cyganek, Izabela

AU - Jayaram, Hiremagalur N.

AU - Crabb, David

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Background: AMP-dependent protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR) α facilitate fatty acid oxidation. We have shown that treatment of hepatoma cells with ethanol or feeding ethanol-containing diets to mice inhibited both PPARα and AMPK activity. Importantly, WY-14,643 reversed the development of fatty liver in alcohol-fed mice. Whether WY-14,643, a PPARα agonist, has any effects on AMPK is not known. The aim of this study was to investigate the effect of WY-14,643 on AMPK activity. Methods: The effect of WY-14,643 on AMPK phosphorylation and activity were examined in rat hepatoma cells (H4IIEC3). The effect of WY-14,643 on upstream kinases of AMPK, PKC-ζ/LKB1, intracellular AMP:ATP ratio, oxidative stress, and AMPK gene expression were studied. Results: Treatment of the H4IIEC3 cells with WY-14,643 for 24 h led to 60% increase in the phosphorylation of AMPK. The effect of WY-14,643 on AMPK phosphorylation is PKC-ζ/LKB1 independent. WY-14,643 did not alter the levels of intracellular AMP:ATP ratio and it did not increase the levels of reactive oxygen species at 24-h of treatment. WY-14,643-induced AMPK α subunit expression by 2- to 2.5-fold, but there was no change in AMPKα subunit protein at 24 h. The effect of WY-14,643 on AMPK phosphorylation did not altered by the presence of an NADPH oxidase inhibitor. Conclusions: WY-14,643 induced AMPKα subunit phosphorylation and the activity of the enzyme. This was associated with induction of AMPKα1 and α2 mRNA, but the mechanism for this activation is uncertain.

AB - Background: AMP-dependent protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR) α facilitate fatty acid oxidation. We have shown that treatment of hepatoma cells with ethanol or feeding ethanol-containing diets to mice inhibited both PPARα and AMPK activity. Importantly, WY-14,643 reversed the development of fatty liver in alcohol-fed mice. Whether WY-14,643, a PPARα agonist, has any effects on AMPK is not known. The aim of this study was to investigate the effect of WY-14,643 on AMPK activity. Methods: The effect of WY-14,643 on AMPK phosphorylation and activity were examined in rat hepatoma cells (H4IIEC3). The effect of WY-14,643 on upstream kinases of AMPK, PKC-ζ/LKB1, intracellular AMP:ATP ratio, oxidative stress, and AMPK gene expression were studied. Results: Treatment of the H4IIEC3 cells with WY-14,643 for 24 h led to 60% increase in the phosphorylation of AMPK. The effect of WY-14,643 on AMPK phosphorylation is PKC-ζ/LKB1 independent. WY-14,643 did not alter the levels of intracellular AMP:ATP ratio and it did not increase the levels of reactive oxygen species at 24-h of treatment. WY-14,643-induced AMPK α subunit expression by 2- to 2.5-fold, but there was no change in AMPKα subunit protein at 24 h. The effect of WY-14,643 on AMPK phosphorylation did not altered by the presence of an NADPH oxidase inhibitor. Conclusions: WY-14,643 induced AMPKα subunit phosphorylation and the activity of the enzyme. This was associated with induction of AMPKα1 and α2 mRNA, but the mechanism for this activation is uncertain.

KW - AMPKα

KW - PPARα agonist

KW - WY-14,643

UR - http://www.scopus.com/inward/record.url?scp=64549119693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64549119693&partnerID=8YFLogxK

U2 - 10.1016/j.abb.2009.02.006

DO - 10.1016/j.abb.2009.02.006

M3 - Article

VL - 485

SP - 10

EP - 15

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

IS - 1

ER -